反应详情

To a stirred solution of t-butyl 3-acetoxymethyl-7-aminoceph-3-em-4-carboxylate (164 mg.) in anhydrous CH2Cl2 at room temperature was added a molar solution of anhydrous toluene-p-sulphonic acid in CH2Cl2 (0.5 ml.) and then 1-(2,2-diethoxyethyl)-3-trimethylsilylcarbodiimide (125 μl.). Stirring was continued for 10 minutes and the solvent was evaporated. The residue, t-butyl 3-acetoxymethyl-7-[2-(2,2-diethoxyethyl)-3-trimethylsilyl]guanidinoceph-3-em-4-carboxylate, was dissolved in acetonitrile and 12N aqueous HCl (42 μl.) added. The mixture was stirred for 1.5 hours at room temperature, and the solvent evaporated. To the residue, t-butyl 3-acetoxymethyl-7-(imidazol-2 -yl)aminoceph-3-em-4-carboxylate, was added trifluoracetic acid and the mixture was stirred for 15 minutes. The solvent was evaporated and the residue was precipitated from a solution in the minimum of CH2Cl2 with ether. The precipitate was dissolved in CH2Cl2 /MeOH and the solvent evaporated to give 3-acetoxymethyl- 7-(imidazol-2-yl)aminoceph-3-em-4-carboxylic acid (262 mg. of 42% strength), identical with the product obtained in Example 2 (yield from 7-amino derivative 65%).

1. customthe solvent was evaporated
2. dissolutionThe residue, t-butyl 3-acetoxymethyl-7-[2-(2,2-diethoxyethyl)-3-trimethylsilyl]guanidinoceph-3-em-4-carboxylate, was dissolved in acetonitrile
3. addition12N aqueous HCl (42 μl.) added
4. stirringThe mixture was stirred for 1.5 hours at room temperature
5. customthe solvent evaporated
6. additionTo the residue, t-butyl 3-acetoxymethyl-7-(imidazol-2 -yl)aminoceph-3-em-4-carboxylate, was added trifluoracetic acid
7. stirringthe mixture was stirred for 15 minutes
8. customThe solvent was evaporated
9. customthe residue was precipitated from a solution in the minimum of CH2Cl2 with ether
10. dissolutionThe precipitate was dissolved in CH2Cl2 /MeOH
11. customthe solvent evaporated